Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19.

Joht Singh ChandanDawit Tefra ZemedikunRasiah ThayakaranNathan ByneSamir DhallaDionisio Acosta-MenaKrishna M GokhaleTom ThomasChristopher SainsburyAnuradhaa SubramanianJennifer CooperAstha AnandKelvin O OkothJingya WangNicola J AdderleyThomas TavernerAlastair K DennistonJanet LordG Neil ThomasChristopher D BuckleyKarim RazaNeeraj BhalaKrishnarajah NirantharakumarShamil Haroon

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

No increase in the risk of suspected or confirmed COVID-19 or mortality was observed among patients with OA in a primary care setting who were prescribed NSAIDs as compared to those who received comparator drugs. These results are reassuring and suggest that in the absence of acute illness, NSAIDs can be safely prescribed during the ongoing pandemic.

Keyphrases

coronavirus disease
sars cov
primary care
drug induced
respiratory syndrome coronavirus
liver failure
anti inflammatory drugs
cardiovascular events
respiratory failure
pulmonary embolism
risk factors
cardiovascular disease
knee osteoarthritis
general practice
mechanical ventilation